Volume 71, Issue 6, Pages e171-e172 (June 2017)

Slides:

Advertisements

Similar presentations

Volume 70, Issue 2, Pages (August 2016)

Advertisements

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Volume 63, Issue 5, Pages (May 2013)

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Volume 57, Issue 6, Pages (June 2010)

Volume 57, Issue 3, Pages e22-e23 (March 2010)

Volume 199, Issue 4, Pages e235-e236 (April 2018)

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 3, Pages (September 2015)

Volume 70, Issue 6, Pages (December 2016)

Volume 69, Issue 1, Pages 4-6 (January 2016)

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Volume 66, Issue 6, Pages (December 2014)

Volume 54, Issue 4, Pages (October 2008)

Bladder Cancer: Management and Future Directions

Let the Games Begin (with EAU Approval)

Ashish M. Kamat, Sima Porten European Urology

Volume 64, Issue 3, Pages (September 2013)

Prostate Cancer Epidemic in Sight?

Re: Marcus G. Cumberbatch, Matteo Rota, James W. F

Volume 63, Issue 4, Pages (April 2013)

Volume 63, Issue 1, Pages (January 2013)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Bladder Cancer: A Major Public Health Issue

Volume 66, Issue 2, Pages (August 2014)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

What is New in Bladder Cancer Diagnosis and Management?

Nomograms for Bladder Cancer

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 51, Issue 5, Pages (May 2007)

Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 4, Pages (April 2012)

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Re: David J. McConkey, Woonyoung Choi, Colin P. N. Dinney

Volume 68, Issue 1, Pages (July 2015)

Volume 61, Issue 6, Pages (June 2012)

Shaheen Alanee, Kasmintan Schrader, Kenneth Offit European Urology

Volume 64, Issue 3, Pages (September 2013)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Laurent Boccon-Gibod European Urology Supplements

Prostate Cancer Epidemic in Sight?

Volume 71, Issue 6, Pages (June 2017)

Volume 70, Issue 1, Pages e27-e28 (July 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 66, Issue 6, Pages (December 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 68, Issue 6, Pages e134-e135 (December 2015)

Volume 70, Issue 2, Pages (August 2016)

European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 3, Pages (March 2009)

Volume 54, Issue 4, Pages (October 2008)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology is “Your” Journal

Volume 52, Issue 4, Pages (October 2007)

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Volume 53, Issue 6, Pages (June 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Bertrand Tombal, Richard Berges

Volume 52, Issue 1, Pages (July 2007)

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Maximilian Burger, Ashish M. Kamat, David McConkey

Presentation transcript:

Volume 71, Issue 6, Pages e171-e172 (June 2017) Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non– muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447–61 Harry Herr European Urology Volume 71, Issue 6, Pages e171-e172 (June 2017) DOI: 10.1016/j.eururo.2016.11.030 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Five-yr progression-free survival of nonmuscle-invasive bladder cancer patients by the presence or absence of tumor at 3 mo and 6 mo (yes/no) after the start of induction Bacillus Calmette–Guérin therapy. pts=patients. European Urology 2017 71, e171-e172DOI: (10.1016/j.eururo.2016.11.030) Copyright © 2016 European Association of Urology Terms and Conditions